Summary & Overview
CPT 78599: Unlisted Respiratory Diagnostic Nuclear Medicine Procedure
CPT code 78599 is the unlisted CPT code for respiratory diagnostic nuclear medicine procedures and is used when no specific respiratory nuclear medicine CPT code applies. Nationally, unlisted codes like 78599 are important because they provide a billing pathway for uncommon, bespoke, or emerging pulmonary imaging studies that rely on radiopharmaceuticals to evaluate lung function or pathology. Proper use of 78599 ensures these services can be reported when clinical circumstances fall outside established code definitions.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for respiratory nuclear medicine, payer coverage considerations, and typical sites of service. The publication outlines how 78599 differs from specific CPT codes, the role of unlisted codes in supporting novel or atypical procedures, and practical documentation expectations that payers commonly require for adjudication.
This report does not provide state-specific guidance. It aims to inform clinicians, coding professionals, and revenue cycle staff about where 78599 fits in the coding landscape, what to expect from major national payers, and which clinical scenarios commonly lead to use of an unlisted respiratory nuclear medicine code.
Billing Code Overview
CPT code 78599 is an unlisted respiratory diagnostic nuclear medicine procedure. It is used to report a respiratory-focused nuclear medicine study for which no specific CPT code exists. The code captures diagnostic imaging procedures that evaluate pulmonary function or other respiratory system processes using radiopharmaceuticals when a listed code does not apply.
Service type: Diagnostic respiratory nuclear medicine procedure
Typical site of service: Hospital outpatient department or imaging center
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with progressive dyspnea and suspected chronic thromboembolic pulmonary hypertension is referred for a specialized respiratory nuclear medicine study that does not have a specific CPT code. The patient arrives at an outpatient hospital-based nuclear medicine department after referral from a pulmonologist. Pre-procedure assessment includes review of anticoagulation status, allergies to radiopharmaceutical components, and explanation of procedure risks. A radiopharmacist prepares a tailored inhaled or intravenous radiotracer and the nuclear medicine technologist performs positioning, monitoring, and image acquisition using planar and SPECT/CT techniques as clinically indicated. The interpreting nuclear medicine physician documents the study, including tracer type, imaging protocol, any technical modifications, and the diagnostic interpretation. The procedure may be used when anatomic imaging and standard perfusion/ventilation studies are insufficient or when an experimental or modified respiratory diagnostic technique is required. Typical sites of service are outpatient hospital imaging centers or freestanding nuclear medicine facilities. The visit may require coordination with pulmonary medicine, cardiology, and anesthesia for complex patients.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required is substantially greater than usual for the respiratory nuclear medicine procedure (document justification). |